Verra Therapeutics, Inc.
Biotechnology company · Lansing, New York, United States
Verra Therapeutics, Inc. is a biotechnology company headquartered in Lansing, New York, United States. Its earliest recorded incorporation is in 2024. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $2.4 million in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $205,000 sold in a notice filed in 2026.
Verra Therapeutics at a glance
What does Verra Therapeutics do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $2.4 million in total (2019 to 2023). NIH funding came from the National Heart, Lung, and Blood Institute.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $205,000 sold (2026).
Frequently asked questions about Verra Therapeutics
Where is Verra Therapeutics headquartered?
Verra Therapeutics, Inc. is headquartered in Lansing, New York, United States.
What does Verra Therapeutics do?
Verra Therapeutics, Inc. is a biotechnology company.
When was Verra Therapeutics founded?
The earliest incorporation on record for Verra Therapeutics, Inc. is in 2024, according to public company registers.
Similar companies
- Novasterilis, Inc.Lansing, New York, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences